Biora Therapeutics Inc (BIOR) — Cash Flow-to-Debt Ratio
Biora Therapeutics Inc (BIOR) has a Cash Flow-to-Debt Ratio of -0.07x as of September 2024, meaning its operating cash flow of $-8.73 Million could theoretically repay 0% of its total liabilities ($121.13 Million) in one year. See BIOR FCF to total liabilities ratio to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Biora Therapeutics Inc Cash Flow-to-Debt Ratio (2018–2023)
Historical debt coverage capacity for Biora Therapeutics Inc across 6 annual periods. For the full cash flow conversion analysis, see Biora Therapeutics Inc operating cash flow efficiency.
Annual Cash Flow-to-Debt Ratio for Biora Therapeutics Inc (2018–2023)
Year-by-year debt coverage analysis for Biora Therapeutics Inc. Check how high is Biora Therapeutics Inc's earnings quality to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2023 | -0.37x | $-48.50 Million | $132.64 Million | ▲ +11.6% |
| 2022 | -0.41x | $-64.42 Million | $155.81 Million | ▲ +52.2% |
| 2021 | -0.86x | $-167.49 Million | $193.81 Million | ▼ -36.3% |
| 2020 | -0.63x | $-165.74 Million | $261.43 Million | ▼ -10.9% |
| 2019 | -0.57x | $-106.12 Million | $185.60 Million | ▼ -34.6% |
| 2018 | -0.42x | $-65.13 Million | $153.37 Million | — |